Literature DB >> 7136440

The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer.

H Pedersen, H S Hansen, C Cederqvist, J Løber.   

Abstract

166 patients suffering from oesophageal cancer were subdivided into two groups with respect to weight loss. Survival of patients with less than or equal to 10% weight loss was significantly longer than in patients with greater 10% weight loss. Within the group with less than or equal 10% weight loss, patients in initial poor physical condition who improved on parenteral nutrition did as well as those in a spontaneously good condition. 159 could be stage-grouped according to the UICC classification. This classification did not give a clear-cut stratification with respect to survival. If the patients were reclassified into three stages in a system combining UICC stages with degree of weight loss, significant differences in survival between the individual stages could be obtained. It is recommended that the degree of weight loss is integrated in the stage-grouping of oesophageal cancer.

Entities:  

Mesh：

Year:  1982        PMID： 7136440

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN： 0001-5482


  7 in total

1.  Weight loss in cancer patients: a plea for a better awareness of the issue.

Authors:  Luigi Mariani; Salvatore Lo Vullo; Federico Bozzetti
Journal:  Support Care Cancer       Date:  2011-01-06       Impact factor: 3.603

2.  Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2008-06-26       Impact factor: 3.603

3.  Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma.

Authors:  Masanori Ikeda; Shoji Natsugoe; Shinichi Ueno; Masamichi Baba; Takashi Aikou
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

4.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

Review 5.  Nutritional support in patients with oesophageal cancer.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2009-06-24       Impact factor: 3.603

6.  Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer.

Authors:  Mari Kogo; Ayako Suzuki; Kazuhiro Kaneko; Keiichiro Yoneyama; Michio Imawari; Yuji Kiuchi
Journal:  Dig Dis Sci       Date:  2008-02-08       Impact factor: 3.199

Review 7.  Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19.

Authors:  J Arends; G Zuercher; A Dossett; R Fietkau; M Hug; I Schmid; E Shang; A Zander
Journal:  Ger Med Sci       Date:  2009-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.